The Patent Finder

Gri Bio, Inc.

13 patents currently held · Updated Nov 15, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Vallon Pharmaceuticals, Inc. (to 2024)

0
Ending by 2030
May 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 15, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,143,668Hydroxy-substituted amino and ammonium derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,829,506Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,453,642Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,564,895Hydroxy-substituted amino and ammonium derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,815,195Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,949,996Prevention and treatment of inflammatory conditions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,925,886Prevention and treatment of inflammatory conditions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,660,309Prevention and Treatment of Inflammatory Conditions
In force
 · Low confidence
In forceLow confidence
US 10,952,977Hydroxy-substituted amino and ammonium derivatives and their medical use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,573,886Hydroxy-substituted amino and ammonium derivatives and their medical use
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 4 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited